GUARNIERI, GIANFRANCO
 Distribuzione geografica
Continente #
NA - Nord America 15.556
AS - Asia 6.109
EU - Europa 5.867
SA - Sud America 587
AF - Africa 163
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 20
Totale 28.329
Nazione #
US - Stati Uniti d'America 15.348
SG - Singapore 2.296
CN - Cina 1.573
IT - Italia 969
SE - Svezia 951
UA - Ucraina 839
PL - Polonia 576
VN - Vietnam 563
HK - Hong Kong 532
DE - Germania 523
BR - Brasile 436
FI - Finlandia 408
FR - Francia 362
KR - Corea 317
GB - Regno Unito 302
RU - Federazione Russa 248
TR - Turchia 235
BD - Bangladesh 186
BG - Bulgaria 146
IE - Irlanda 144
NL - Olanda 124
IN - India 120
CA - Canada 119
CH - Svizzera 71
JP - Giappone 63
AR - Argentina 61
MA - Marocco 53
BE - Belgio 52
MX - Messico 46
SN - Senegal 31
ZA - Sudafrica 26
CO - Colombia 23
ES - Italia 23
AU - Australia 21
IQ - Iraq 21
SA - Arabia Saudita 21
TH - Thailandia 21
RS - Serbia 20
PK - Pakistan 19
PH - Filippine 18
VE - Venezuela 18
EC - Ecuador 17
ID - Indonesia 16
AE - Emirati Arabi Uniti 14
LT - Lituania 14
AT - Austria 13
EG - Egitto 13
EU - Europa 13
JO - Giordania 12
IL - Israele 11
RO - Romania 11
CZ - Repubblica Ceca 10
DK - Danimarca 10
TW - Taiwan 10
AZ - Azerbaigian 9
KE - Kenya 9
UZ - Uzbekistan 9
MY - Malesia 8
PE - Perù 8
TT - Trinidad e Tobago 8
A2 - ???statistics.table.value.countryCode.A2??? 7
CL - Cile 7
OM - Oman 6
PT - Portogallo 6
PY - Paraguay 6
CR - Costa Rica 5
HN - Honduras 5
JM - Giamaica 5
NG - Nigeria 5
SI - Slovenia 5
SV - El Salvador 5
TN - Tunisia 5
UY - Uruguay 5
AL - Albania 4
DZ - Algeria 4
IR - Iran 4
KZ - Kazakistan 4
MK - Macedonia 4
MP - Marianne Settentrionali, isole 4
SK - Slovacchia (Repubblica Slovacca) 4
AM - Armenia 3
BO - Bolivia 3
BY - Bielorussia 3
EE - Estonia 3
HR - Croazia 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
MD - Moldavia 3
MT - Malta 3
PR - Porto Rico 3
AO - Angola 2
BB - Barbados 2
BF - Burkina Faso 2
CG - Congo 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
Totale 28.291
Città #
Woodbridge 1.676
Fairfield 1.526
Ashburn 1.435
Singapore 1.387
Ann Arbor 1.338
Houston 1.304
Chandler 942
Jacksonville 748
Wilmington 709
San Jose 667
Seattle 628
Hong Kong 518
Cambridge 513
Warsaw 430
Hefei 399
Beijing 344
Seoul 305
Princeton 272
Boardman 262
Trieste 189
Chicago 187
Izmir 187
Los Angeles 186
Ho Chi Minh City 163
Hanoi 148
Dublin 144
Columbus 143
Sofia 143
Lauterbourg 131
Milan 129
Zgierz 128
Helsinki 127
Santa Clara 119
The Dalles 111
Dearborn 110
Moscow 101
Buffalo 99
Frankfurt am Main 99
Dallas 89
San Diego 77
New York 74
Düsseldorf 73
Munich 71
Bern 57
Grafing 57
Brussels 49
São Paulo 49
London 47
Casablanca 46
Des Moines 46
Tokyo 45
Verona 45
Atlanta 37
Montreal 35
Phoenix 35
Turku 33
Falls Church 32
Da Nang 31
Dakar 31
Bremen 30
Guangzhou 30
Washington 30
Nanjing 29
Chennai 28
Council Bluffs 28
Kunming 27
Shanghai 27
Shenyang 27
Orem 26
Tianjin 26
Ottawa 25
Denver 24
Mestre 24
Auburn Hills 23
Brooklyn 23
Toronto 23
Norwalk 22
Jinan 21
Redondo Beach 20
Rio de Janeiro 20
Belgrade 19
San Francisco 19
Haiphong 18
Memphis 18
Stockholm 18
Boston 17
Nuremberg 16
Pune 16
Rome 16
Bangkok 15
Johannesburg 15
Venice 15
Amsterdam 14
Ankara 14
Hải Dương 14
Fremont 13
Miano 13
Zhengzhou 13
Charlotte 12
Chengdu 12
Totale 19.946
Nome #
Unacylated ghrelin reduces skeletal muscle reactive oxygen species generation and inflammation and prevents high-fat diet-induced hyperglycemia and whole-body insulin resistance in rodents 526
Unacylated ghrelin does not alter mitochondrial function, redox state and triglyceride content in rat liver in vivo 408
Central adiposity markers, plasma lipid profile and cardiometabolic risk prediction in overweight-obese individuals 349
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 327
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 321
Unacylated ghrelin normalizes skeletal muscle oxidative stress and prevents muscle catabolism by enhancing tissue mitophagy in experimental chronic kidney disease 317
Acylated Ghrelin Limits Fat Accumulation and Improves Redox State and Inflammation Markers in the Liver of High-Fat-Fed Rats. 308
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 305
Adipokines, Ghrelin and Obesity-Associated Insulin Resistance in Nondiabetic Patients with Acute Coronary Syndrome. 304
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 300
Coagulation indicators in patients with paroxysmal atrial fibrillation: Effects of electric and pharmacologic cardioversion. 294
Growth hormone decreases muscle glutamine production and stimulates protein synthesis in hypercatabolic patients. 289
Serum Response Factor depletion affects the proliferation of the hepatocellular carcinoma cells HepG2 and JHH6 281
D-dimer and anticoagulation in patients with mechanical prosthetic heart valves. A 2-year follow-up. 276
Decreased IL-10 mRNA expression in patients with advanced renal failure undergoing conservative treatment 273
Current strategies to improve the efficacy and the delivery of nucleic acid based drugs 267
High-fat diet with acyl-ghrelin treatment leads to weight gain with low inflammation, high oxidative capacity and normal triglycerides in rat muscle. 260
Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome 260
Amino acid and protein therapy in chronic renal failure. 257
Characterization of nucleic acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices 255
Nutrition in Renal Disease 254
Pentoxifylline acutely reduces protein catabolism in chronically uremic patients. 253
Alcohol reduces MMP-2 in humans and isolated smooth muscle cells. 253
Gastric bypass-induced weight loss alters obesity-associated patterns of plasma pentraxin-3 and systemic inflammatory markers 251
Plasma total and unacylated ghrelin predict 5-year changes in insulin resistance 251
Fatty acids acutely enhance insulin-induced oxidative stress and cause insulin resistance by increasing mitochondrial reactive oxygen species (ROS) generation and nuclear factor-κB inhibitor (IκB)-nuclear factor-κB (NFκB) activation in rat muscle, in the absence of mitochondrial dysfunction. 248
Relationship between whole-body protein turnover and serum creatinine in chronically uremic patients. 247
Whey protein ingestion enhances postprandial anabolism during short-term bed rest in young men. 246
Sarcopenic obesity in free-living older adults detected by the ESPEN-EASO consensus diagnostic algorithm: Validation in an Italian cohort and predictive value of insulin resistance and altered plasma ghrelin profile 241
Calorie restriction modulates inactivity-induced changes in the inflammatory markers C-reactive protein and pentraxin-3 233
Metabolic response to injury and sepsis: changes in protein metabolism. 231
MMP-9 microsatellite polymorphism: association with the progression of intima-media thickening and constrictive remodeling of carotid atherosclerotic plaques. 228
Physical inactivity decreases whole body glutamine turnover independently from changes in proteolysis. 224
Effects of growth hormone administration on skeletal muscle glutamine metabolism in severely traumatized patients: preliminary report. 221
Mechanisms of malnutrition in uremia. 214
Plasma concentrations of interleukin-2 soluble receptor in mild ischaemic left ventricular dysfunction. 214
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 212
Time-dependent changes in plasma total, acylated and desacylated ghrelin after gastric by-pass 212
Carnitine metabolism in uremia 208
n-3-Pufa Dietary Enrichment Improves Whole-Body Insulin Action and Normalizes Muscle Mass, Mitochondrial Function, Oxidative Stress, and Insulin Signalling in Experimental Uremia 207
Coagulation indicators in chronic stable effort angina and unstable angina: relationship with acute phase reactants and clinical outcome. 205
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 201
Characterization of liposomes for the delivery of SiRNAs in the treatment of coronary restenosis 199
Slower activation of insulin action in hypertension associated with obesity. 199
MMP-9 microsatellite polymorphism and multiple sclerosis. 195
Overexpression of the elongation factor 1A1 relates to muscle proteolysis and proapoptotic p66(ShcA) gene transcription in hypercatabolic trauma patients. 195
Fighting protein-energy wasting in chronic kidney disease: a challenge of complexity. 195
Modulation of protein kinetics in chronic renal failure. 193
Effects of L-carnitine supplementation in the dialysate on serum lipoprotein composition of hemodialysis patients. 192
MMP-9 microsatellite polymorphism and susceptibility to exudative form of age-related macular degeneration. 191
Sensitivity of whole body protein synthesis to amino acid administration during short-term bed rest. 189
Rheological and mechanical properties of pluronic-alginate gels for drug-eluting stent coating 187
Cyclin E1, E2 and E2F1 targeted siRNAs down regulate the growth of coronary smooth muscle cell, thus showing their potential use in the prevention of in-stent restenosis 187
Differential Cross-Sectional and Prospective Predictive Value for Insulin Resistance of Different Anthropometric Indexes and Parameters in A North-East Italy Community-Based Population Cohort 187
In-hospital outcome of patients with acute coronary syndrome: relationship with inflammation and remodeling markers. 184
Antibiotics and renal tubular damage in cirrhosis. 183
Intravenous lipid infusion and total plasma fatty acids positively modulate plasma acylated ghrelin in vivo 181
Evaluation of dietary compliance in patients with chronic renal failure on conservative treatment: comparison of methods to assess dietary intake 174
Molecular regulation of protein catabolism in trauma patients. 174
Potential applications of small interferring RNA in the cardiovascular field 173
The Kidney 170
Proliferation of human primary vascular smooth muscle cells depends on serum response factor. 168
Charactherization of liposomes for the delivery of siRNAs in the treatment of coronary restenosis 168
The Association between Hematological Parameters and Insulin Resistance Is Modified by Body Mass Index – Results from the North-East Italy MoMa Population Study 167
Rheological properties of aqueous Pluronic-alginate systems containing liposomes 167
Association of interferon-gamma +874A polymorphism with reduced long-term inflammatory response in haemodialysis patients. 166
Gastric bypass does not normalize obesity-related changes in ghrelin profile and leads to higher acylated ghrelin fraction 165
Higher total ghrelin levels are associated with higher insulin-mediated glucose disposal in non-diabetic maintenance hemodialysis patients. 164
Propaedeutic study for the delivery of nucleic acid-based molecules from PLGA microparticles and stearic acid nanoparticles 164
Clinical Nutrition 161
High plasma retinol binding protein 4 (RBP4) is associated with systemic inflammation independently of low RBP4 adipose expression and is normalized by transplantation in nonobese, nondiabetic patients with chronic kidney disease 161
Lipid-lowering effect of carnitine in chronically uremic patients treated with maintenance hemodialysis 160
Therapeutic potential of hammerhead ribozymes in the treatment of hyper-proliferative diseases 160
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 159
Metalloproteinases-2, -9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI. 157
Nutritional assessment in patients with early renal insufficiency on long-term low protein diet. 156
null 155
Nutritional and metabolic effects of ten years of protein-restricted diet in patients with early renal failure 155
Unacylated Ghrelin Normalizes Oxidative Stress and Insulin Action in Rat Muscle and Prevents Muscle Loss in Experimental Uremia 155
Effects of erythropoietin administration on nutritional state and erythrocyte metabolism in maintenance hemodialysis patients. 154
Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. 154
Long term prognosis in patients with peripheral arterial disease treated with antiplatelet agents. 152
null 152
Slower activation of insulin action in upper body obesity. 151
SiRNAs targeted against cyclin E1, cyclin E2 and E2F1 down regulate the growth of Hepatocellular Carcinoma showing their potential use in the prevention of this type of tumor 149
Simple methods for nutritional assessment in hemodialyzed patients 148
Metabolic syndrome and chronic kidney disease. 147
Role of E2F1-cycline1-cycline2 circuit in hepatocellular carcinoma cell proliferation and therapeutic potential of its down-regulation by siRNAs 146
Advances in carnitine in chronic uremia 146
Role of E2F1–Cyclin E1-Cyclin E2 Circuit in Human Coronary Smooth Muscle Cell Proliferation and Therapeutic Potential of Its Downregulation by siRNAs 145
Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome. 144
Ghrelin enhances in vivo skeletal muscle but not liver AKT signaling in rats 143
Calorie restriction accelerates the catabolism of lean body mass during 2 wk of bed rest. 143
The kidney 142
Muscle cathepsin D activity, and RNA, DNA and protein content in maintenance hemodialysis patients. 140
Unacylated Ghrelin: A Novel Regulator of Muscle Intermediate Metabolism With Potential Beneficial Effects in Chronic Kidney Disease 140
Effects of various promoter derived sequences on the cleavage kinetic of an hammerhead ribozyme directed against cyclin E1 mRNA. 137
Caloric restriction improves endothelial dysfunction during vascular aging: Effects on nitric oxide synthase isoforms and oxidative stress in rat aorta. 137
Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile 136
null 134
Totale 20.727
Categoria #
all - tutte 81.434
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.434


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.780 71 120 60 186 64 190 69 52 187 190 181 410
2022/20232.607 233 336 201 393 238 476 7 223 316 20 135 29
2023/20241.354 151 104 93 83 141 119 253 168 12 35 109 86
2024/20253.022 46 80 212 286 313 299 215 155 399 375 285 357
2025/20267.625 727 402 535 633 703 766 1.229 221 788 985 321 315
2026/202714 14 0 0 0 0 0 0 0 0 0 0 0
Totale 28.857